Improving Sunitinib Efficacy and tolerability in patients with metastatic clear cell carcinoma of the kidney by using a 14/7 day schedule and ToxicityAdjusted Dosing (ISE TAD147)
- Gurney, Howard (Primary Chief Investigator)
Project: Research
Project: Research